Submitted by Anonymous (not verified) on 15 September 2023 - 9:41
Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Multiple Sclerosis, Date of authorisation: 17/03/2011, Revision: 36, Status: Authorised
Source: